BG
BRLI

BlackRock Group’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

BlackRock Group’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-22,338
Closed -$921K – 3146
2015
Q2 		$921K Buy
22,338
+4,668
+26% +$167K ﹤0.01% 1996
2015
Q1 		$622K Buy
17,670
+3,294
+23% +$111K ﹤0.01% 2104
2014
Q4 		$462K Sell
14,376
-1,095
-7% -$31.7K ﹤0.01% 2267
2014
Q3 		$435K Sell
15,471
-633
-4% -$19.3K ﹤0.01% 2229
2014
Q2 		$487K Sell
16,104
-3,928
-20% -$108K ﹤0.01% 2212
2014
Q1 		$554K Sell
20,032
-3,312
-14% -$86.7K ﹤0.01% 2209
2013
Q4 		$596K Buy
23,344
+3,604
+18% +$111K ﹤0.01% 2172
2013
Q3 		$590K Buy
19,740
+4,410
+29% +$123K ﹤0.01% 2162
2013
Q2 		$441K Buy
+15,330
New +$422K ﹤0.01% 2089

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

BlackRock Group's BRLI Position: Q3 2015 in Review

BlackRock Group sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 22,338 shares — an estimated $921K sold.

BlackRock Group first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $921K in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • BlackRock Group reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • BlackRock Group sold 22,338 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $921K.
  • BlackRock Group first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • BlackRock Group's BIO-REFERENCE LABS INC-NEW- position peaked at $921K in Q2 2015.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on BlackRock Group's 13F filing for Q3 2015, filed 13 Nov 2015.